Genome instability in Maple Syrup Urine Disease correlates with impaired mitochondrial biogenesis

Metabolism. 2014 Aug;63(8):1063-70. doi: 10.1016/j.metabol.2014.05.003. Epub 2014 May 9.

Abstract

Objective: The mitochondrial branched-chain ketoacid dehydrogenase (BCKD) catalyzes the degradation of branched-chain amino acids (BCAA), which have been shown to induce oxidative stress. Maple Syrup Urine Disease (MSUD) is caused by impaired activity of BCKD, suggesting that oxidative stress and resulting DNA damage could contribute to pathology. We evaluated the potential effect of BCKD deficiency on genome integrity and mitochondrial function as a downstream target.

Methods: Primary fibroblasts from MSUD patients and controls were either cultivated under normal conditions or exposed to metabolic or oxidative stress. DNA was analyzed for damage and mitochondrial function was evaluated by gene expression analyses, functional assays and immunofluorescent methods.

Results: Patient fibroblasts accumulated damage in mitochondrial DNA (mtDNA) and nuclear DNA, with a corresponding reduction in mitochondrial transcription, mtDNA copy number and pyruvate dehydrogenase. We found no evidence of increased level of reactive oxygen species (ROS) in patient fibroblasts under normal conditions, suggesting that the genotoxic effect is ascribed to accumulating metabolites.

Conclusions: Impaired BCKD activity as in MSUD, results in accumulation of DNA damage and corresponding mitochondrial dysfunction.

Keywords: BCKA; DNA damage; MSUD; PDH; mitochondrial biogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acids, Branched-Chain / metabolism
  • Base Sequence
  • Case-Control Studies
  • DNA Damage
  • DNA Primers
  • Genomic Instability*
  • Humans
  • Maple Syrup Urine Disease / genetics*
  • Mitochondria / metabolism*
  • Oxidative Stress

Substances

  • Amino Acids, Branched-Chain
  • DNA Primers